Table 3.

CT findings seen in 143 lobes of 24 immunocompromised patients

Findings	RUL	RML	RLL	LUL	Lingula	LLL	Total
Lesion extent	17 (23)	20 (24)	19 (24)	21 (24)	20 (24)	19 (24)	116 (143)
Bronchiectasis	11 (23)	17 (24)	9 (24)	15 (24)	15 (24)	9 (24)	76 (143)
Small opacity
Ill-defined nodule
Cavity (−)	8 (23)	12 (24)	14 (24)	9 (24)	12 (24)	15 (24)	70 (143)
Cavity (+)	6 (23)	1 (24)	1 (24)	1 (24)	2 (24)	4 (24)	15 (143)
Well-defined nodule
Cavity (−)	4 (23)	4 (24)	4 (24)	5 (24)	4 (24)	7 (24)	28 (143)
Cavity (+)	1 (23)	0 (24)	0 (24)	0 (24)	0 (24)	0 (24)	1 (143)
Large opacity
1–2 cm
Cavity (−)	9 (23)	7 (24)	5 (24)	4 (24)	7 (24)	4 (24)	36 (143)
Cavity (+)	2 (23)	0 (24)	0 (24)	2 (24)	1 (24)	0 (24)	5 (143)
>2 cm
Cavity (−)	2 (23)	5 (24)	2 (24)	3 (24)	6 (24)	2 (24)	20 (143)
Cavity (+)	5 (23)	2 (24)	1 (24)	8 (24)	6 (24)	3 (24)	25 (143)

LLL, left lower lobe; LUL, left upper lobe; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe.

Number in parenthesis indicates the number of lobes evaluated in the 24 patients.